NWPIF yields 183.49% · JNJ yields 2.13%● Live data
📍 NWPIF pulled ahead of the other in Year 1
Combined, NWPIF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NWPIF + JNJ for your $10,000?
ClearStream Energy Services Inc. provides upstream, midstream, and downstream production services in Canada and the United States. The company operates through Maintenance and Construction Services, and Wear Technology Overlay Services segments. The Maintenance and Construction Services segment provides operational, maintenance, welding, fabrication, machining, construction, and turnaround services to the conventional oil and gas, oilsands, and other industries, as well as abandonment, decommissioning, and reclamation services. This segment also offers resource/labour supply services to Canadian energy companies, as well as heavy equipment operators. The Wear Technology Overlay Services segment specializes in the supply and fabrication of overlay pipe spools, pipe bends, and wear plates and vessels for corrosion and abrasion resistant applications in various end markets. The company also provides regulatory and environmental advisory services; and electrical and instrumentation services. It serves oil and gas, energy, mining, agriculture, pulp and paper, petrochemical, and water treatment industries. The company was formerly known as Tuckamore Capital Management Inc. and changed its name to ClearStream Energy Services Inc. in October 2016. ClearStream Energy Services Inc. was founded in 1967 and is headquartered in Calgary, Canada.
Full NWPIF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.